Author:
McFarland Taylor Ryan,Tandar Clara Elizabeth,Agarwal Neeraj,Swami Umang
Reference24 articles.
1. PARP and PARG inhibitors in cancer treatment;Slade;Genes Dev,2020
2. Olaparib (LYNPARZA®) [package insert], AstraZeneca. (2020) https://azpicentral.com/lynparza_tb/lynparza_tb.pdf. (accessed December 14, 2020).
3. Rucaparib (RUBRACA®) [package insert], Clovis Oncol. (2020) https://clovisoncology.com/pdfs/RubracaUSPI.pdf. (accessed December 14, 2020).
4. Integrative Clinical Genomics of Advanced Prostate Cancer;Robinson;Cell.,2015
5. W. Abida, J. Armenia, A. Gopalan, R. Brennan, M. Walsh, D. Barron, D. Danila, D. Rathkopf, M. Morris, S. Slovin, B. McLaughlin, K. Curtis, D.M. Hyman, J.C. Durack, S.B. Solomon, M.E. Arcila, A. Zehir, A. Syed, J. Gao, D. Chakravarty, H.A. Vargas, M.E. Robson, J. Vijai, K. Offit, M.T.A. Donoghue, A.A. Abeshouse, R. Kundra, Z.J. Heins, A. V. Penson, C. Harris, B.S. Taylor, M. Ladanyi, D. Mandelker, L. Zhang, V.E. Reuter, P.W. Kantoff, D.B. Solit, M.F. Berger, C.L. Sawyers, N. Schultz, H.I. Scher, Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision Making, JCO Precis. Oncol. (2017) 1–16. 10.1200/PO.17.00029.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Multiple drugs;Reactions Weekly;2022-01